These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38304461)

  • 21. Activity of
    Valzano F; Boncompagni SR; Micieli M; Di Maggio T; Di Pilato V; Colombini L; Santoro F; Pozzi G; Rossolini GM; Pallecchi L
    Microbiol Spectr; 2022 Aug; 10(4):e0100622. PubMed ID: 35735984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis.
    Di Bonaventura G; Lupetti V; Di Giulio A; Muzzi M; Piccirilli A; Cariani L; Pompilio A
    Microbiol Spectr; 2023 Aug; 11(4):e0035223. PubMed ID: 37306577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staphylococcus aureus Protein A Mediates Interspecies Interactions at the Cell Surface of Pseudomonas aeruginosa.
    Armbruster CR; Wolter DJ; Mishra M; Hayden HS; Radey MC; Merrihew G; MacCoss MJ; Burns J; Wozniak DJ; Parsek MR; Hoffman LR
    mBio; 2016 May; 7(3):. PubMed ID: 27222468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro inhibitory activity of N-acetylcysteine on tympanostomy tube biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
    Jun Y; Youn CK; Jo ER; Cho SI
    Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109622. PubMed ID: 31404783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection.
    Baldan R; Cigana C; Testa F; Bianconi I; De Simone M; Pellin D; Di Serio C; Bragonzi A; Cirillo DM
    PLoS One; 2014; 9(3):e89614. PubMed ID: 24603807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interbacterial Antagonism Mediated by a Released Polysaccharide.
    Liu Y; Gloag ES; Hill PJ; Parsek MR; Wozniak DJ
    J Bacteriol; 2022 May; 204(5):e0007622. PubMed ID: 35446119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections.
    Durfey SL; Pipavath S; Li A; Vo AT; Ratjen A; Carter S; Morgan SJ; Radey MC; Grogan B; Salipante SJ; Welsh MJ; Stoltz DA; Goss CH; McKone EF; Singh PK
    mBio; 2021 Dec; 12(6):e0314821. PubMed ID: 34903059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinatorial effects of antibiotics and enzymes against dual-species Staphylococcus aureus and Pseudomonas aeruginosa biofilms in the wound-like medium.
    Fanaei Pirlar R; Emaneini M; Beigverdi R; Banar M; B van Leeuwen W; Jabalameli F
    PLoS One; 2020; 15(6):e0235093. PubMed ID: 32584878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus.
    Camus L; Briaud P; Vandenesch F; Doléans-Jordheim A; Moreau K
    Adv Exp Med Biol; 2022; 1386():397-424. PubMed ID: 36258081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly (acetyl, arginyl) glucosamine disrupts
    Garcia BA; McDaniel MS; Loughran AJ; Johns JD; Narayanaswamy V; Fernandez Petty C; Birket SE; Baker SM; Barnaby R; Stanton BA; Foote JB; Rowe SM; Swords WE
    Microbiology (Reading); 2022 Jan; 168(1):. PubMed ID: 35077346
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term coexistence of
    Monteiro R; Magalhães AP; Pereira MO; Sousa AM
    Future Microbiol; 2021 Aug; 16():879-893. PubMed ID: 34319132
    [No Abstract]   [Full Text] [Related]  

  • 32. Sustained Coinfections with
    Fischer AJ; Singh SB; LaMarche MM; Maakestad LJ; Kienenberger ZE; Peña TA; Stoltz DA; Limoli DH
    Am J Respir Crit Care Med; 2021 Feb; 203(3):328-338. PubMed ID: 32750253
    [No Abstract]   [Full Text] [Related]  

  • 33. Biofilm-forming capacity of Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa from ocular infections.
    Hou W; Sun X; Wang Z; Zhang Y
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5624-31. PubMed ID: 22736609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
    Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiofilm Activities of Borneol-Citral-Loaded Pickering Emulsions against Pseudomonas aeruginosa and Staphylococcus aureus in Physiologically Relevant Chronic Infection Models.
    Wang W; Bao X; Bové M; Rigole P; Meng X; Su J; Coenye T
    Microbiol Spectr; 2022 Oct; 10(5):e0169622. PubMed ID: 36194139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo anti-biofilm activity of pyran derivative against Staphylococcus aureus and Pseudomonas aeruginosa.
    Su S; Yin P; Li J; Chen G; Wang Y; Qu D; Li Z; Xue X; Luo X; Li M
    J Infect Public Health; 2020 May; 13(5):791-799. PubMed ID: 31813834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Rosenfeld M; Rayner O; Smyth AR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD001912. PubMed ID: 32997797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis.
    Charrier C; Rodger C; Robertson J; Kowalczuk A; Shand N; Fraser-Pitt D; Mercer D; O'Neil D
    Orphanet J Rare Dis; 2014 Nov; 9():189. PubMed ID: 25433388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic in vivo mutations within the ica operon during persistence of Staphylococcus aureus in the airways of cystic fibrosis patients.
    Schwartbeck B; Birtel J; Treffon J; Langhanki L; Mellmann A; Kale D; Kahl J; Hirschhausen N; Neumann C; Lee JC; Götz F; Rohde H; Henke H; Küster P; Peters G; Kahl BC
    PLoS Pathog; 2016 Nov; 12(11):e1006024. PubMed ID: 27902784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.
    Mainz JG; Naehrlich L; Schien M; Käding M; Schiller I; Mayr S; Schneider G; Wiedemann B; Wiehlmann L; Cramer N; Pfister W; Kahl BC; Beck JF; Tümmler B
    Thorax; 2009 Jun; 64(6):535-40. PubMed ID: 19282318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.